EIAV S2 enhances pro-inflammatory cytokine and chemokine response in infected macrophages

Virology

Volumn 397, Issue 1, 2010, Pages 217-223

  Covaleda, Lina ^a   Fuller, Frederick J ^b   Payne, Susan L ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Chemokines; Cytokines; Dysregulation; EIAV; Gene expression; Macrophage; Real time PCR

Indexed keywords

CHEMOKINE; COMPLEMENTARY DNA; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 34; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 2; PROTEIN S II; RNA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADULT ANIMAL; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; EQUINE INFECTIOUS ANEMIA VIRUS; GENE EXPRESSION; HORSE DISEASE; HOST CELL; IMMUNE RESPONSE; MACROPHAGE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; VIRUS REPLICATION;

ANIMALS; CELLS, CULTURED; CYTOKINES; GENE DELETION; GENE EXPRESSION PROFILING; HORSES; INFECTIOUS ANEMIA VIRUS, EQUINE; MACROPHAGES; VIRAL PROTEINS;

EQUINE INFECTIOUS ANEMIA VIRUS;

EID: 73949105727     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.11.005     Document Type: Article

References (50)

1. Akridge R.E., Oyafuso L.K., and Reed S.G. IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J. Immunol. 153 12 (1994) 5782-5789
2. Allen C.A., Payne S.L., Harville M., Cohen N., and Russell K.E. Validation of quantitative polymerase chain reaction assays for measuring cytokine expression in equine macrophages. J. Immunol. Methods 328 1-2 (2007) 59-69
3. Bozza F.A., Cruz O.G., Zagne S.M., Azeredo E.L., Nogueira R.M., Assis E.F., Bozza P.T., and Kubelka C.F. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect. Dis. 8 (2008) 86
4. Broxmeyer H.E., Sherry B., Cooper S., Ruscetti F.W., Williams D.E., Arosio P., Kwon B.S., and Cerami A. Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth. J. Immunol. 147 8 (1991) 2586-2594
5. Broxmeyer H.E., Sherry B., Cooper S., Lu L., Maze R., Beckmann M.P., Cerami A., and Ralph P. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression. J. Immunol. 150 8 Pt. 1 (1993) 3448-3458
6. Carroll R., and Derse D. Translation of equine infectious anemia virus bicistronic tat-rev mRNA requires leaky ribosome scanning of the tat CTG initiation codon. J. Virol. 67 3 (1993) 1433-1440
7. Cheevers W.P., and McGuire T.C. Equine infectious anemia virus: immunopathogenesis and persistence. Rev. Infect. Dis. 7 1 (1985) 83-88
8. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., and de Vries J.E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174 5 (1991) 1209-1220
9. Dean G.A., and Pedersen N.C. Cytokine response in multiple lymphoid tissues during the primary phase of feline immunodeficiency virus infection. J. Virol. 72 12 (1998) 9436-9440
10. Fagerness A.J., Flaherty M.T., Perry S.T., Jia B., Payne S.L., and Fuller F.J. The S2 accessory gene of equine infectious anemia virus is essential for expression of disease in ponies. Virology 349 1 (2006) 22-30
11. Foil L.D., and Issel C.J. Transmission of retroviruses by arthropods. Annu. Rev. Entomol. 36 (1991) 355-381
12. Hammond S.A., Li F., McKeon Sr. B.M., Cook S.J., Issel C.J., and Montelaro R.C. Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus. J. Virol. 74 13 (2000) 5968-5981
13. Issel C.J., Adams Jr. W.V., Meek L., and Ochoa R. Transmission of equine infectious anemia virus from horses without clinical signs of disease. J. Am. Vet. Med. Assoc. 180 3 (1982) 272-275
14. Kedzierska K., Crowe S.M., Turville S., and Cunningham A.L. The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages. Rev. Med. Virol. 13 1 (2003) 39-56
15. Kinter A., Catanzaro A., Monaco J., Ruiz M., Justement J., Moir S., Arthos J., Oliva A., Ehler L., Mizell S., Jackson R., Ostrowski M., Hoxie J., Offord R., and Fauci A.S. CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: role of signal transduction. Proc. Natl. Acad. Sci. U.S.A. 95 20 (1998) 11880-11885
16. Lane B.R., Lore K., Bock P.J., Andersson J., Coffey M.J., Strieter R.M., and Markovitz D.M. Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy. J. Virol. 75 17 (2001) 8195-8202
17. Lane B.R., King S.R., Bock P.J., Strieter R.M., Coffey M.J., and Markovitz D.M. The C-X-C chemokine IP-10 stimulates HIV-1 replication. Virology 307 1 (2003) 122-134
18. Leroux C., Cadore J.L., and Montelaro R.C. Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?. Vet. Res. 35 4 (2004) 485-512
19. Li F., Puffer B.A., and Montelaro R.C. The S2 gene of equine infectious anemia virus is dispensable for viral replication in vitro. J. Virol. 72 10 (1998) 8344-8348
20. Li F., Leroux C., Craigo J.K., Cook S.J., Issel C.J., and Montelaro R.C. The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies. J. Virol. 74 1 (2000) 573-579
21. Li F., Craigo J.K., Howe L., Steckbeck J.D., Cook S., Issel C., and Montelaro R.C. A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses. J. Virol. 77 13 (2003) 7244-7253
22. Lichtenstein D.L., Rushlow K.E., Cook R.F., Raabe M.L., Swardson C.J., Kociba G.J., Issel C.J., and Montelaro R.C. Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity. J. Virol. 69 5 (1995) 2881-2888
23. Lim W.S., Payne S.L., Edwards J.F., Kim I., and Ball J.M. Differential effects of virulent and avirulent equine infectious anemia virus on macrophage cytokine expression. Virology 332 1 (2005) 295-306
24. Lin H., Lee E., Hestir K., Leo C., Huang M., Bosch E., Halenbeck R., Wu G., Zhou A., Behrens D., Hollenbaugh D., Linnemann T., Qin M., Wong J., Chu K., Doberstein S.K., and Williams L.T. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320 5877 (2008) 807-811
25. Linenberger M.L., Shelton G.H., Persik M.T., and Abkowitz J.L. Hematopoiesis in asymptomatic cats infected with feline immunodeficiency virus. Blood 78 8 (1991) 1963-1968
26. Maurer M., and von Stebut E. Macrophage inflammatory protein-1. Int. J. Biochem. Cell Biol. 36 10 (2004) 1882-1886
27. Maury W. Monocyte maturation controls expression of equine infectious anemia virus. J. Virol. 68 10 (1994) 6270-6279
28. Maze R., Sherry B., Kwon B.S., Cerami A., and Broxmeyer H.E. Myelosuppressive effects in vivo of purified recombinant murine macrophage inflammatory protein-1 alpha. J. Immunol. 149 3 (1992) 1004-1009
29. McGuire T.C., O'Rourke K.I., and Perryman L.E. Immunopathogenesis of equine infectious anemia lentivirus disease. Dev. Biol. Stand. 72 (1990) 31-37
30. Menten P., Wuyts A., and Van Damme J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev. 13 6 (2002) 455-481
31. Minano F.J., Fernandez-Alonso A., Myers R.D., and Sancibrian M. Hypothalamic interaction between macrophage inflammatory protein-1 alpha (MIP-1 alpha) and MIP-1 beta in rats: a new level for fever control. J. Physiol. 491 Pt. 1 (1996) 209-217
32. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19 (2001) 683-765
33. Oaks J.L., McGuire T.C., Ulibarri C., and Crawford T.B. Equine infectious anemia virus is found in tissue macrophages during subclinical infection. J. Virol. 72 9 (1998) 7263-7269
34. Orandle M.S., Williams K.C., MacLean A.G., Westmoreland S.V., and Lackner A.A. Macaques with rapid disease progression and simian immunodeficiency virus encephalitis have a unique cytokine profile in peripheral lymphoid tissues. J. Virol. 75 9 (2001) 4448-4452
35. Ott M., Lovett J.L., Mueller L., and Verdin E. Superinduction of IL-8 in T cells by HIV-1 Tat protein is mediated through NF-{kapa}B factors. J. Immunol. 160 (1998) 2872-2880
36. Payne S.L., Pei X.F., Jia B., Fagerness A., and Fuller F.J. Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus. J. Virol. 78 5 (2004) 2478-2485
37. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 9 (2001) e45
38. Prost S., Le Dantec M., Auge S., Le Grand R., Derdouch S., Auregan G., Deglon N., Relouzat F., Aubertin A.M., Maillere B., Dusanter-Fourt I., and Kirszenbaum M. Human and simian immunodeficiency viruses deregulate early hematopoiesis through a Nef/PPARgamma/STAT5 signaling pathway in macaques. J. Clin. Invest. 118 5 (2008) 1765-1775
39. Reinhart T.A. Chemokine induction by HIV-1: recruitment to the cause. Trends Immunol. 24 7 (2003) 351-353
40. Russell K.E., Perkins P.C., Hoffman M.R., Miller R.T., Walker K.M., Fuller F.J., and Sellon D.C. Platelets from thrombocytopenic ponies acutely infected with equine infectious anemia virus are activated in vivo and hypofunctional. Virology 259 1 (1999) 7-19
41. Schiltz R.L., Shih D.S., Rasty S., Montelaro R.C., and Rushlow K.E. Equine infectious anemia virus gene expression: characterization of the RNA splicing pattern and the protein products encoded by open reading frames S1 and S2. J. Virol. 66 6 (1992) 3455-3465
42. Schmidtmayerova H., Nottet H.S., Nuovo G., Raabe T., Flanagan C.R., Dubrovsky L., Gendelman H.E., Cerami A., Bukrinsky M., and Sherry B. Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc. Natl. Acad. Sci. U.S.A. 93 2 (1996) 700-704
43. Sellon D.C. Equine infectious anemia. Vet. Clin. North Am., Equine Pract. 9 2 (1993) 321-336
44. Sellon D.C., Fuller F.J., and McGuire T.C. The immunopathogenesis of equine infectious anemia virus. Virus Res. 32 2 (1994) 111-138
45. Sellon D.C., Walker K.M., Russell K.E., Perry S.T., Covington P., and Fuller F.J. Equine infectious anemia virus replication is upregulated during differentiation of blood monocytes from acutely infected horses. J. Virol. 70 1 (1996) 590-594
46. Steinberg H.N., Crumpacker C.S., and Chatis P.A. In vitro suppression of normal human bone marrow progenitor cells by human immunodeficiency virus. J. Virol. 65 4 (1991) 1765-1769
47. Swardson C.J., Kociba G.J., and Perryman L.E. Effects of equine infectious anemia virus on hematopoietic progenitors in vitro. Am. J. Vet. Res. 53 7 (1992) 1176-1179
48. Threadgill D.S., Steagall W.K., Flaherty M.T., Fuller F.J., Perry S.T., Rushlow K.E., Le Grice S.F., and Payne S.L. Characterization of equine infectious anemia virus dUTPase: growth properties of a dUTPase-deficient mutant. J. Virol. 67 5 (1993) 2592-2600
49. Tornquist S.J., Oaks J.L., and Crawford T.B. Elevation of cytokines associated with the thrombocytopenia of equine infectious anaemia. J. Gen. Virol. 78 Pt. 10 (1997) 2541-2548
50. Yoon S., Kingsman S.M., Kingsman A.J., Wilson S.A., and Mitrophanous K.A. Characterization of the equine infectious anaemia virus S2 protein. J. Gen. Virol. 81 Pt. 9 (2000) 2189-2194